(114 days)
LC Bead LUMI is intended to be used for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
LC Bead LUMI™ is an imageable spherical embolic product that can be visualised by X-ray based imaging (e.g. fluoroscopy and CT). The beads are non-resorbable microspheres with calibrated size ranges. LC Bead LUMI™ are intended to be used for the embolization of hypervascular tumours and arteriovenous malformations (AVM). LC Bead LUMI™ are supplied in a saline buffer solution within a sealed glass vial. A vial access device is also provided within the secondary packaging. LC Bead LUMI™ is provided sterile (moist heat sterilization). LC Bead LUMI™ consist of a macromer derived from a sulphonate modified polyvinyl alcohol (PVA) macromer which contains a radiopaque moiety that is covalently bound within the hydrogel structure. The incorporation of this radiopaque moiety into the co-polymer imparts X-ray imageability by rendering the microspheres radiopaque. LC Bead LUMI™ has been designed as a radiopaque version of LC Bead™. Currently embolization with LC Bead™ lacks post-procedural imaging feedback on exact bead location. The embolization process with LC Bead™ is monitored by detecting changes in antegrade flow of soluble iodinated contrast in which the beads are diluted. The embolization is continued until a desired embolization endpoint is reached. This process is completed without specific feedback on the bead location. In order to address this limitation, the manufacturer has developed an imageable spherical embolic bead that can be visualized by X-ray based imaging. At the time of use, LC Bead LUMI™ is mixed with non-ionic contrast agent in order to monitor the delivery of the product during the embolization procedure. LC Bead LUMI™ is delivered via typical microcatheters to physically block the target vessel. Once the product has been delivered the iodine moiety allows for visualization of the microspheres. LC Bead LUMI™ is a single use, tissue contacting, implantable device available only for prescription use.
This document is a 510(k) premarket notification for a medical device called "LC Bead LUMI." It focuses on demonstrating substantial equivalence to a predicate device, rather than proving that an AI/ML powered device meets specific acceptance criteria through a clinical study. Therefore, the information requested in your prompt (e.g., acceptance criteria for AI performance, sample sizes for test sets, expert adjudication, MRMC studies) is not present in this document.
The document primarily addresses the physical and material characteristics of the LC Bead LUMI, its intended use, and a comparison with existing predicate devices to demonstrate that it is as safe and effective as the legally marketed predicate.
Here's a breakdown of why the requested information isn't available based on the provided text:
- Device Type: LC Bead LUMI is described as an "imageable spherical embolic product" and "non-resorbable microspheres." It is a physical medical device (embolic beads), not an AI/ML powered medical device.
- Study Type: The performance data mentioned are "Bench testing data, verification studies and in-vivo safety and performance studies." These are engineering and animal studies to demonstrate physical properties, biocompatibility, and embolization effectiveness, not clinical trials evaluating AI performance.
- "Acceptance Criteria" in this context: The "acceptance criteria" here refer to the criteria for demonstrating substantial equivalence to a predicate device under 510(k) regulations, not performance metrics for an AI algorithm.
- "Performance Data" in this context: The "performance data" refers to the safety and performance of the physical embolic beads themselves, such as their ability to embolize, their radiopacity, and their biocompatibility, as opposed to the diagnostic or treatment recommendation performance of an AI.
Therefore, I cannot fill out the requested table or provide answers to the specific questions regarding AI/ML device performance and study design, as this document does not pertain to an AI/ML powered medical device.
§ 870.3300 Vascular embolization device.
(a)
Identification. A vascular embolization device is an intravascular implant intended to control hemorrhaging due to aneurysms, certain types of tumors (e.g., nephroma, hepatoma, uterine fibroids), and arteriovenous malformations. This does not include cyanoacrylates and other embolic agents, which act by polymerization or precipitation. Embolization devices used in neurovascular applications are also not included in this classification, see § 882.5950 of this chapter.(b)
Classification. Class II (special controls.) The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.” For availability of this guidance document, see § 870.1(e).